Anfomed GmbH   Report issue

For profit Phase 4
Founded: Mohrendord Germany (1977)

Organization Overview

First Clinical Trial
2011
NCT01323491
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Anfomed GmbH